東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Investigating the role of advanced g...

Whalin, Matthew K.

Linked to FindBook

Google Book

Amazon

博客來

Investigating the role of advanced glycation endproducts and the NADPH oxidase in diabetic vascular disease.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Investigating the role of advanced glycation endproducts and the NADPH oxidase in diabetic vascular disease./
Author:	Whalin, Matthew K.
Description:	100 p.
Notes:	Adviser: W. Robert Taylor.
Contained By:	Dissertation Abstracts International69-04B.
Subject:	Biology, Physiology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3310302
ISBN:	9780549587859

Investigating the role of advanced glycation endproducts and the NADPH oxidase in diabetic vascular disease.
Whalin, Matthew K.

Investigating the role of advanced glycation endproducts and the NADPH oxidase in diabetic vascular disease. - 100 p.

Adviser: W. Robert Taylor.

Thesis (Ph.D.)--Emory University, 2008.

The formation of advanced glycation endproducts (AGEs) and the production of reactive oxygen species (ROS) are two mechanisms by which diabetes mellitus may induce a pro-inflammatory state and lead to the development of cardiovascular disease. This dissertation recounts two studies designed to test the ability of AGEs to produce ROS and stimulate the expression of pro-inflammatory genes in the vasculature. The first study examined the role of AGEs in inducing the expression of the protein subunits of the NADPH oxidase, a major source of ROS in blood vessels. AGEs activated the NADPH oxidase to produce ROS in the aortas of mice. Treatment with AGEs, both in vivo and ex vivo, also induced aortic expression of many of the same NADPH oxidase subunits which were observed in diabetic mice. This represents the first evidence of AGEs as a mediator of the increased levels of NADPH oxidase proteins which have been observed in diabetic animals and humans. The second study examined the role of NADPH oxidase activation in mediating the induction of pro-inflammatory genes by AGEs.

ISBN: 9780549587859Subjects--Topical Terms:

1017816
Biology, Physiology.

Investigating the role of advanced glycation endproducts and the NADPH oxidase in diabetic vascular disease.
LDR:02901nam 2200301 a 45 001 940895
005 20110518
008 110518s2008 ||||||||||||||||| ||eng d
020 $a 9780549587859
035 $a (UMI)AAI3310302
035 $a AAI3310302
040 $a UMI $c UMI
100 1 $a Whalin, Matthew K. $3 1265028
245 1 0 $a Investigating the role of advanced glycation endproducts and the NADPH oxidase in diabetic vascular disease.
300 $a 100 p.
500 $a Adviser: W. Robert Taylor.
500 $a Source: Dissertation Abstracts International, Volume: 69-04, Section: B, page: 2257.
502 $a Thesis (Ph.D.)--Emory University, 2008.
520 $a The formation of advanced glycation endproducts (AGEs) and the production of reactive oxygen species (ROS) are two mechanisms by which diabetes mellitus may induce a pro-inflammatory state and lead to the development of cardiovascular disease. This dissertation recounts two studies designed to test the ability of AGEs to produce ROS and stimulate the expression of pro-inflammatory genes in the vasculature. The first study examined the role of AGEs in inducing the expression of the protein subunits of the NADPH oxidase, a major source of ROS in blood vessels. AGEs activated the NADPH oxidase to produce ROS in the aortas of mice. Treatment with AGEs, both in vivo and ex vivo, also induced aortic expression of many of the same NADPH oxidase subunits which were observed in diabetic mice. This represents the first evidence of AGEs as a mediator of the increased levels of NADPH oxidase proteins which have been observed in diabetic animals and humans. The second study examined the role of NADPH oxidase activation in mediating the induction of pro-inflammatory genes by AGEs.
520 $a Administration of AGEs to mice stimulated aortic expression of vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1), two proteins which are increased in the vasculature of patients with diabetes. Apocynin, an inhibitor of NADPH oxidase activation, blocked the AGE-mediated increase in VCAM-1 and MCP-1. The same inhibition occurred in isolated endothelial and vascular smooth muscle cells. The studies of mouse aortic tissue provide a link between clinical studies of diabetes and cell culture studies of AGE effects. Together, these studies suggest a role for AGE-mediated NADPH oxidase activation in the promotion of inflammation in the diabetic vasculature. A key implication of this work is that the AGE signaling pathway and the NADPH oxidase represent important therapeutic targets for the treatment of diabetic vascular disease.
590 $a School code: 0665.
650 4 $a Biology, Physiology. $3 1017816
650 4 $a Health Sciences, Medicine and Surgery. $3 1017756
650 4 $a Health Sciences, Pharmacology. $3 1017717
690 $a 0419
690 $a 0564
690 $a 0719
710 2 $a Emory University. $3 1017429
773 0 $t Dissertation Abstracts International $g 69-04B.
790 $a 0665
790 1 0 $a Taylor, W. Robert, $e advisor
791 $a Ph.D.
792 $a 2008
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3310302